Antiarrhythmic Drug Dosing in Children—Review of the Literature
Children, 2023 Antiarrhythmic drugs represent a mainstay of pediatric arrhythmia treatment. However, official guidelines and consensus documents on this topic remain scarce. There are rather uniform recommendations for some medications (including adenosine, amiodarone,
Nathalie Oeffl +8 more
doaj +1 more source
Antiarrhythmic Drug Therapy in Cardiomyopathies: A Comparative Synthesis of Guidelines and Consensus Documents. [PDF]
Curr Cardiol RepPurpose of Review Antiarrhythmic drug therapy in cardiomyopathies remains challenging because arrhythmic risk, drug efficacy, and pro-arrhythmic vulnerability vary substantially across phenotypes.
Palermi A +9 more
europepmc +2 more sources
AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
, 2022 Hepatology, EarlyView.
Robert J. Fontana +6 more
wiley +1 more source
Historical Aspects of the Use of Antiarrhythmic Drugs in Clinical Practice
Рациональная фармакотерапия в кардиологии, 2022 Heart rhythm disorders are one of the most urgent problems in cardiology. The first reports on the possibility of using drugs in the treatment of cardiac arrhythmias began to appear in the scientific literature from the middle of the 18th century.
V. L. Doshchitsin, A. I. Tarzimanova
doaj +1 more source
Рациональная фармакотерапия в кардиологии, 2016 Aim. Comparative study of amiodarone and bisoprolol efficacy in patients with ventricular arrhythmia and metabolic syndrome.Methods. 146 patients with the AHA/NHLBI 2005 metabolic syndrome and symptomatic ventricular arrhythmia were included in the study.
V. M. Provotorov, M. L. Gluhovsky
doaj +3 more sources
Mechanisms of termination and prevention of atrial fibrillation by drug therapy [PDF]
, 2011 Atrial fibrillation (AF) is a disorder of the rhythm of electrical activation of the cardiac atria. It is the most common cardiac arrhythmia, has multiple aetiologies, and increases the risk of death from stroke.
Smith, G.L. +5 more
core +1 more source
Mexiletine: Antiarrhythmic mechanisms, emerging clinical applications and mortality
, 2023 Mexiletine, a class Ib antiarrhythmic drug, exhibits its major antiarrhythmic effect via inhibition of the fast and late Na currents in myocardial tissues that are dependent on the opening of Na channels for their excitation.
Tse, Gary +5 more
core +1 more source
Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation [PDF]
, 1992 Background and Objectives.The relation between cardiac mortality and antiarrhythmic drug administration has not been fully determined. This relation was analyzed in 1,330 patients enrolled in the Stroke Prevention in Atrial Fibrillation Study, a ...
Flaker, Greg C. +5 more
core +1 more source
Drug Therapy in Atrial Fibrillation Management: Where Do We Stand in 2010? [PDF]
Journal of Tehran University Heart Center, 2010 Atrial fibrillation (AF) is a commonly encountered arrhythmia in our daily practice. Every year a huge bulk of data is published about different management strategies, new antiarrhythmic drugs, anticoagulation protocols and ablation procedures in these ...
Mehdi Montazeri, Gholamreza Davoodi
doaj +2 more sources
Triple Antiarrhythmic Therapy in Newborns with Refractory Atrioventricular Reentrant Tachycardia
, 2023 Atrioventricular reentrant tachycardia (AVRT) is the most common form of supraventricular tachycardia in newborns. AVRT is sometimes refractory to conventional antiarrhythmic therapy.
Romeo, Emanuele +8 more
core +1 more source